Patent · US Active

EZH2 inhibitors for treating lymphoma

US11642347B2 · kind B2 · utility

5Cited by

15References

10Claims

0Family size

Assignees

Epizyme, Inc. · US
Eisai R&D Management Co., Ltd. · JP

Inventors

Heike KEILHACK · Belmont, US
Sarah K. Knutson · Lincoln, US
Danielle Johnston BLACKWELL · Cambridge, US
Larisa Reyderman · Watchung, US
Lone Ottesen · London, GB

Key dates

Filing date	Mar 4, 2020
Grant date	May 9, 2023
Priority date	—
Expiry date	Dec 23, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.